Dr. Ajaz Bhat works as a senior staff scientist at Sidra Medicine, Qatar. He completed his Ph.D at All India Institute of Medical Sciences, AIIMS, New Delhi, one of the premier medical institutes in India, focusing on vaccine immunology. After his Ph.D, he moved to Vanderbilt University Medical School (VUMS), Nashville, TN, USA, for a postdoctoral fellowship. During his eleven years of post-PhD training, he gained broad experience in the pathobiological importance of tight junction proteins (Claudins) in colorectal cancer and the role of bile acid-induced APE1/Ref1 in the pathogenesis of esophageal cancer. His research at Sidra Medicine focuses on drug discovery, signaling networks in cancer, cancer metabolism, cancer genomics, obesity, and diabetes. He has published in well-reputed journals like Nature Communications, GUT, Oncogene, Cancer Research, Molecular Cancer, and many more. He has attended many international meetings, conferences, and symposia to present his research results and received awards from the Immunology Society and the American Association of Cancer Research. He was also awarded as an outstanding researcher from Sidra Medicine. He is an active member of many immunology and cancer societies and serves on the editorial board and review committee of many peer-reviewed journals.